192 related articles for article (PubMed ID: 22068287)
21. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
22. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
23. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
24. Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART.
Franzetti M; Adorni F; Parravicini C; Vergani B; Antinori S; Milazzo L; Galli M; Ridolfo AL
J Acquir Immune Defic Syndr; 2013 Apr; 62(4):414-20. PubMed ID: 23274934
[TBL] [Abstract][Full Text] [Related]
25. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
26. AIDS-related cancers in the era of highly active antiretroviral therapy.
Biggar RJ
Oncology (Williston Park); 2001 Apr; 15(4):439-48; discussion 448-9. PubMed ID: 11346932
[TBL] [Abstract][Full Text] [Related]
27. Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.
Shiels MS; Cole SR; Wegner S; Armenian H; Chmiel JS; Ganesan A; Marconi VC; Martinez-Maza O; Martinson J; Weintrob A; Jacobson LP; Crum-Cianflone NF
J Acquir Immune Defic Syndr; 2008 Aug; 48(4):485-90. PubMed ID: 18614916
[TBL] [Abstract][Full Text] [Related]
28. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era.
Serraino D; De Paoli A; Zucchetto A; Pennazza S; Bruzzone S; Spina M; De Paoli P; Rezza G; Dal Maso L; Suligoi B
Cancer Epidemiol; 2010 Jun; 34(3):257-61. PubMed ID: 20413362
[TBL] [Abstract][Full Text] [Related]
29. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
30. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
31. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
32. Excess cancers among HIV-infected people in the United States.
Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
[TBL] [Abstract][Full Text] [Related]
33. Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.
Haas CB; Engels EA; Horner MJ; Freedman ND; Luo Q; Gershman S; Qiao B; Pfeiffer RM; Shiels MS
Lancet HIV; 2022 Oct; 9(10):e700-e708. PubMed ID: 36179753
[TBL] [Abstract][Full Text] [Related]
34. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
35. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA
JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978
[TBL] [Abstract][Full Text] [Related]
36. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.
Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ
J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
38. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
39. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
[TBL] [Abstract][Full Text] [Related]
40. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]